RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: anxiety disorder
Accession: DOID:2030
browse the term
Definition: A cognitive disorder that involves an excessive, irrational dread of everyday situations. (DO)
Synonyms: exact_synonym: ANXIETY; Neurotic Anxiety State; anxiety disorders; anxiety neuroses; anxiety state; neurotic anxiety states
narrow_synonym: HARM AVOIDANCE
related_synonym: SEROTONIN TRANSPORTER ACTIVITY, INCREASED/DECREASED
primary_id: MESH:D001008
alt_id: OMIM:607834
xref: EFO:0005230 ; EFO:0006788 ; ICD10CM:F41.9 ; NCI:C2878
For additional species annotation, visit the
Alliance of Genome Resources .
GViewer not supported for the selected species.
G
ACE2
angiotensin converting enzyme 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26767952
NCBI chr X:14,032,231...14,094,163
Ensembl chr X:14,030,233...14,077,785
G
ADAR
adenosine deaminase RNA specific
ISO
ClinVar Annotator: match by term: Anxiety
ClinVar
PMID:25741868
NCBI chr20:9,194,611...9,241,102
Ensembl chr20:9,219,937...9,241,329
G
ADORA2A
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12825092 PMID:16118787 PMID:18305461 PMID:20532872
NCBI chr19:7,691,678...7,706,781
Ensembl chr19:7,691,536...7,706,926
G
ADRA2A
adrenoceptor alpha 2A
ISO
RGD
PMID:21669254
RGD:6480479
NCBI chr 9:104,015,577...104,019,364
Ensembl chr 9:104,016,580...104,017,932
G
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32057829
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
APP
amyloid beta precursor protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19664757
NCBI chr 2:66,037,224...66,320,860
Ensembl chr 2:66,037,261...66,321,306
G
ARC
activity regulated cytoskeleton associated protein
ameliorates
ISO
associated with alcohol use disorder associated with alcohol dependence
RGD
PMID:18322102 PMID:21182574 PMID:24103311 PMID:25814047
RGD:401938616 RGD:401938648 RGD:401938652 RGD:401938663
NCBI chr 8:136,857,402...136,860,933
Ensembl chr 8:136,859,438...136,860,628
G
AVPR1B
arginine vasopressin receptor 1B
treatment
ISO
RGD
PMID:21956463 PMID:24654684
RGD:14700666 RGD:14700676
NCBI chr25:23,234,651...23,244,403
Ensembl chr25:23,234,823...23,241,159
G
BDNF
brain derived neurotrophic factor
treatment ameliorates
ISO
associated with alcohol use disorder associated with alcohol dependence
RGD
PMID:18322102 PMID:24103311 PMID:25283985 PMID:25814047
RGD:151356735 RGD:401938616 RGD:401938652 RGD:401938663
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
G
CACNA1C
calcium voltage-gated channel subunit alpha1 C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28696432
NCBI chr11:2,107,722...2,753,970
Ensembl chr11:2,508,705...2,752,991
G
CARTPT
CART prepropeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12600694
NCBI chr 4:66,058,755...66,060,635
Ensembl chr 4:66,058,769...66,061,112
G
CCR2
C-C motif chemokine receptor 2
ISO
associated with Sciatic Neuropathy;
RGD
PMID:24907405
RGD:8661781
NCBI chr22:7,795,192...7,801,242
Ensembl chr22:7,798,646...7,799,728
G
CHD8
chromodomain helicase DNA binding protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35365720
NCBI chr29:21,856,434...21,924,761
Ensembl chr29:21,856,263...21,924,787
G
CHRNA5
cholinergic receptor nicotinic alpha 5 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19220484 PMID:29944862
NCBI chr26:4,747,734...4,779,231
Ensembl chr26:4,749,766...4,776,822
G
CHRNB2
cholinergic receptor nicotinic beta 2 subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23419392
NCBI chr20:9,245,803...9,255,430
Ensembl chr20:9,247,231...9,253,795
G
CNR1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15081793 PMID:18690112
NCBI chr13:12,626,259...12,653,253
Ensembl chr13:12,630,270...12,631,688
G
CREB1
cAMP responsive element binding protein 1
treatment
ISO
associated with alcohol use disorder
RGD
PMID:18322102 PMID:32014377
RGD:401827932 RGD:401938616
NCBI chr10:93,316,774...93,395,187
Ensembl chr10:93,316,840...93,388,832
G
CRH
corticotropin releasing hormone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7816204 PMID:8736133 PMID:11440811 PMID:11875628 PMID:12424556 PMID:12438692 PMID:14575894 PMID:16495007 PMID:17293045 PMID:21268831 PMID:22231481 More...
NCBI chr 8:62,052,155...62,056,424
Ensembl chr 8:62,052,592...62,053,182
G
CRHR2
corticotropin releasing hormone receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10742108
NCBI chr21:27,703,637...27,738,873
Ensembl chr21:27,708,113...27,739,116
G
CRP
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism associated with Coronary Disease;
CTD RGD
PMID:18603621 PMID:20194079
RGD:9491832
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
G
CTNND2
catenin delta 2
susceptibility
ISO
DNA:polymorphism:multiple (human)
RGD
PMID:24256404
RGD:40902831
NCBI chr 4:10,499,822...11,426,432
Ensembl chr 4:10,500,761...10,762,677
G
DISC1
DISC1 scaffold protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29643356
NCBI chr25:68,886,451...69,274,774
Ensembl chr25:68,946,430...69,263,198
G
DIXDC1
DIX domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27752079
NCBI chr 1:103,276,780...103,377,110
Ensembl chr 1:103,286,346...103,378,387
G
DNMT1
DNA methyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23791455
NCBI chr 6:9,199,006...9,263,890
Ensembl chr 6:9,199,003...9,263,607
G
DNMT3B
DNA methyltransferase 3 beta
ISO
mRNA:decreased expression:hypothalamus:
RGD
PMID:23529784
RGD:9588317
NCBI chr 2:37,128,635...37,176,033
Ensembl chr 2:37,146,538...37,174,570
G
DRD2
dopamine receptor D2
ISO
CTD Direct Evidence: marker/mechanism DNA:snp:cds:p.H313H (human)
CTD RGD
PMID:9513185 PMID:18305461 PMID:20532872
RGD:1358603
NCBI chr 1:104,774,632...104,843,417
Ensembl chr 1:104,774,180...104,842,736
G
EOMES
eomesodermin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26415720
NCBI chr15:72,257,626...72,264,563
G
ESR2
estrogen receptor 2
treatment
ISO
RGD
PMID:24015243 PMID:24631553
RGD:10045678 RGD:7364908
NCBI chr24:41,426,333...41,513,802
Ensembl chr24:41,447,224...41,512,486
G
FMR1
Fragile X messenger ribonucleoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28616095
NCBI chr X:122,635,383...122,674,298
Ensembl chr X:122,635,439...122,674,355
G
FNTB
farnesyltransferase, CAAX box, subunit beta
ISO
DNA:SNP:CDS:multiple (human)
RGD
PMID:35642741
RGD:401854249
NCBI chr24:42,197,998...42,275,863
Ensembl chr24:42,198,704...42,276,898
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16488545
NCBI chr24:52,497,465...52,501,161
Ensembl chr24:52,497,521...52,501,514
G
GABRA2
gamma-aminobutyric acid type A receptor subunit alpha2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18313124
NCBI chr27:3,858,741...4,013,385
Ensembl chr27:3,858,910...4,006,582
G
GAD1
glutamate decarboxylase 1
susceptibility
ISO
DNA:snp(s) protein:decreased expression:hippocampus
RGD
PMID:22328461 PMID:28986280
RGD:405850254 RGD:6480264
NCBI chr10:56,351,495...56,396,476
Ensembl chr10:56,353,253...56,396,524
G
GDNF
glial cell derived neurotrophic factor
no_association
ISO
DNA:SNPs, haplotypes:rs3812047, rs3096140 (human) DNA:SNPs:multiple
RGD
PMID:24324616
RGD:405849392
NCBI chr 4:36,662,033...36,691,761
Ensembl chr 4:36,665,009...36,684,257
G
GLO1
glyoxalase I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22113448
NCBI chr17:33,446,134...33,472,240
Ensembl chr17:33,446,145...33,473,699
G
GNB1
G protein subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22113448
NCBI chr20:129,654,890...129,765,765
Ensembl chr20:129,707,085...129,766,667
G
GRM8
glutamate metabotropic receptor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17434465
NCBI chr21:95,264,905...96,060,822
Ensembl chr21:95,264,765...96,050,554
G
HCN1
hyperpolarization activated cyclic nucleotide gated potassium channel 1
ISO
RGD
PMID:22884333
RGD:9686419
NCBI chr 4:44,029,173...44,443,669
G
HDAC2
histone deacetylase 2
ISO
associated with alcohol use disorder ;mRNA,protein:increased expression:amygdala (rat)
RGD
PMID:23485013 PMID:25814047
RGD:401938652 RGD:9590265
NCBI chr13:59,873,248...59,904,542
Ensembl chr13:59,873,767...59,905,742
G
HMBS
hydroxymethylbilane synthase
ISO
ClinVar Annotator: match by term: Anxiety
ClinVar
PMID:25741868
NCBI chr 1:110,457,799...110,466,361
Ensembl chr 1:110,457,537...110,466,095
G
HTR1A
5-hydroxytryptamine receptor 1A
ISO
OMIM:607834
RGD MouseDO
PMID:21512427
RGD:5683629
NCBI chr 4:60,159,542...60,162,947
Ensembl chr 4:60,159,944...60,161,212
G
HTR1B
5-hydroxytryptamine receptor 1B
ISO
RGD
PMID:12040062
RGD:625756
NCBI chr13:2,143,646...2,145,943
Ensembl chr13:2,144,313...2,145,485
G
HTR2C
5-hydroxytryptamine receptor 2C
ISO
RGD
PMID:17074317
RGD:1625000
NCBI chr X:102,190,355...102,499,928
Ensembl chr X:102,325,731...102,497,278
G
HTR7
5-hydroxytryptamine receptor 7
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16828124 PMID:21859099
RGD:6482189
NCBI chr 9:84,081,713...84,191,112
Ensembl chr 9:84,083,396...84,190,876
G
IFNA2
interferon alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12297606
NCBI chr12:58,468,018...58,469,825
G
KDM3B
lysine demethylase 3B
ISO
RGD
PMID:24397026
RGD:9590119
NCBI chr23:41,027,490...41,111,560
Ensembl chr23:41,062,020...41,112,469
G
KLF7
KLF transcription factor 7
ISO
ClinVar Annotator: match by term: Anxiety
ClinVar
PMID:17434132 PMID:18094723 PMID:25741868 PMID:28492532 PMID:29251763
NCBI chr10:92,854,234...92,943,908
Ensembl chr10:92,859,000...92,944,062
G
L1CAM
L1 cell adhesion molecule
ISO
protein:increased expression: brain, multiple (rat)
RGD
PMID:19746433
RGD:6483075
NCBI chr X:128,285,128...128,309,173
Ensembl chr X:128,285,130...128,299,570
G
LOC103231899
ETS transcription factor ELK1
ameliorates
ISO
associated with alcohol use disorder
RGD
PMID:18322102
RGD:401938616
NCBI chr X:44,812,681...44,827,657
G
LOC103243260
corticotropin-releasing factor receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9299637 PMID:22231481
NCBI chr16:60,070,156...60,120,857
Ensembl chr16:60,070,066...60,120,712
G
LOC103246766
cytochrome P450 3A8
ISO
protein:altered activity::treatment
RGD
PMID:17376576
RGD:5685599
NCBI chr28:13,297,566...13,330,023
G
MAGI2
membrane associated guanylate kinase, WW and PDZ domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25653350
NCBI chr21:69,460,345...70,916,684
G
MANEA
mannosidase endo-alpha
susceptibility
ISO
DNA:SNP:3'utr: (rs1133503) (Human)
RGD
PMID:24473444
RGD:401851911
NCBI chr13:20,496,677...20,529,201
Ensembl chr13:20,496,686...20,530,819
G
MAPT
microtubule associated protein tau
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29860433
NCBI chr16:59,894,400...60,020,723
Ensembl chr16:59,890,221...59,955,612
G
MDK
midkine
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19217924
NCBI chr 1:18,945,355...18,948,394
Ensembl chr 1:18,946,378...18,947,134
G
MECP2
methyl-CpG binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22231481
NCBI chr X:128,445,028...128,519,892
Ensembl chr X:128,453,577...128,455,785
G
MIF
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20177408
NCBI chr19:7,000,837...7,001,700
Ensembl chr19:7,000,793...7,001,757
G
NCOR1
nuclear receptor corepressor 1
ISO
RGD
PMID:20051490
RGD:5688287
NCBI chr16:15,442,315...15,629,411
Ensembl chr16:15,462,640...15,628,512
G
NPS
neuropeptide S
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:19339610 PMID:21466221
NCBI chr 9:120,168,749...120,176,288
G
NPY
neuropeptide Y
susceptibility
ISO
DNA:SNPs, haplotypes CTD Direct Evidence: therapeutic
RGD CTD
PMID:11440811 PMID:22328461
RGD:6480264
NCBI chr21:34,068,533...34,076,205
Ensembl chr21:34,068,530...34,075,127
G
NPY1R
neuropeptide Y receptor Y1
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:11440811 PMID:21803058
RGD:10448284
NCBI chr 7:109,774,700...109,794,543
Ensembl chr 7:109,774,918...109,776,905
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ameliorates
ISO
associated with alcohol use disorder
RGD
PMID:18322102
RGD:401938616
NCBI chr12:95,477,612...95,836,734
Ensembl chr12:95,479,447...95,620,364
G
OPRM1
opioid receptor mu 1
treatment
ISO
RGD
PMID:32014377
RGD:401827932
NCBI chr13:81,568,295...81,650,005
Ensembl chr13:81,568,732...81,625,088
G
OXT
oxytocin/neurophysin I prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19228979
NCBI chr 2:33,749,520...33,750,981
Ensembl chr 2:33,750,108...33,750,968
G
PAM
peptidylglycine alpha-amidating monooxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19815072
NCBI chr23:6,316,428...6,482,959
Ensembl chr23:6,316,428...6,486,751
G
RAI1
retinoic acid induced 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18285828
NCBI chr16:16,717,767...16,847,014
Ensembl chr16:16,760,189...16,849,346
G
SERPINA1
serpin family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17659342
NCBI chr24:72,158,521...72,171,139
Ensembl chr24:72,156,784...72,163,500
G
SHANK1
SH3 and multiple ankyrin repeat domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18272690
NCBI chr 6:43,718,904...43,776,814
Ensembl chr 6:43,716,714...43,773,945
G
SLC6A3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19120712
NCBI chr 4:1,209,013...1,258,797
Ensembl chr 4:1,209,019...1,258,866
G
SLC6A4
solute carrier family 6 member 4
ISO
ClinVar Annotator: match by term: Serotonin transporter activity, increased/decreased
OMIM ClinVar
PMID:7865169 PMID:8632190 PMID:8788073 PMID:11335745 PMID:11559314 PMID:11602621 PMID:11772685 PMID:12130784 PMID:12476327 PMID:12599191 PMID:12869766 PMID:12915525 PMID:12966525 PMID:14530202 PMID:14593433 PMID:14735161 PMID:15037864 PMID:15108187 PMID:15263905 PMID:15520364 PMID:15578606 PMID:15592465 PMID:15635638 PMID:15642926 PMID:15691525 PMID:15729746 PMID:15824745 PMID:15867107 PMID:15880108 PMID:16642437 PMID:17101915 PMID:19531786 More...
NCBI chr16:23,929,196...23,969,665
Ensembl chr16:23,927,311...23,955,616
G
TAFA2
TAFA chemokine like family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29339520
NCBI chr11:57,598,179...58,095,527
Ensembl chr11:57,597,697...57,763,149
G
TG
thyroglobulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30373627
NCBI chr 8:127,293,797...127,567,218
Ensembl chr 8:127,293,834...127,567,771
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20194079
G
UCN
urocortin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16488545
NCBI chr14:80,303,210...80,304,910
Ensembl chr14:80,304,416...80,304,790
G
ACHE
acetylcholinesterase (Cartwright blood group)
ISO
RGD
PMID:20645790
RGD:5509849
NCBI chr28:12,328,304...12,335,302
Ensembl chr28:12,331,039...12,335,076
G
CACNA1C
calcium voltage-gated channel subunit alpha1 C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28696432
NCBI chr11:2,107,722...2,753,970
Ensembl chr11:2,508,705...2,752,991
G
CRP
C-reactive protein
ISO
RGD
PMID:19628221
RGD:9585647
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
G
HTR2A
5-hydroxytryptamine receptor 2A
treatment
ISO
RGD
PMID:15507224
RGD:401900762
NCBI chr 3:24,820,029...24,884,472
Ensembl chr 3:24,820,035...24,883,432
G
DBH
dopamine beta-hydroxylase
ISO
ClinVar Annotator: match by term: Orthostatic hypotension 1
OMIM ClinVar
PMID:7715704 PMID:9536098 PMID:11170900 PMID:11857564 PMID:14598346 PMID:15060114 PMID:17576681 PMID:20186791 PMID:21209083 PMID:21471955 PMID:22028891 PMID:23622564 PMID:24033266 PMID:25450229 PMID:25741868 PMID:26762739 PMID:27778639 PMID:28492532 More...
NCBI chr12:4,474,041...4,498,942
Ensembl chr12:4,474,958...4,498,910
G
HSPA5
heat shock protein family A (Hsp70) member 5
ISO
RGD
PMID:21209083
RGD:5685690
NCBI chr12:12,920,705...12,925,888
Ensembl chr12:12,920,710...12,927,431
G
GPER1
G protein-coupled estrogen receptor 1
severity
ISO
protein:increased expression:serum (human)
RGD
PMID:27512921
RGD:39938860
NCBI chr28:20,491,874...20,497,966
Ensembl chr28:20,492,188...20,493,315
G
HTR1B
5-hydroxytryptamine receptor 1B
sexual_dimorphism
ISO
associated with attention deficit hyperactivity disorder;DNA:SNPs: :rs11568817, rs6296(human)
RGD
PMID:28923721
RGD:405650695
NCBI chr13:2,143,646...2,145,943
Ensembl chr13:2,144,313...2,145,485
G
SLC6A4
solute carrier family 6 member 4
treatment
ISO
DNA:repeats, haplotype:promoter:
RGD
PMID:22907732
RGD:36947386
NCBI chr16:23,929,196...23,969,665
Ensembl chr16:23,927,311...23,955,616
G
ZNF462
zinc finger protein 462
ISO
MouseDO
NCBI chr12:32,532,853...32,687,262
Ensembl chr12:32,520,334...32,685,464
G
SLC6A2
solute carrier family 6 member 2
ISO
ClinVar Annotator: match by term: Neurocirculatory asthenia
ClinVar
PMID:10684912 PMID:11875370
NCBI chr 5:41,434,004...41,482,568
Ensembl chr 5:41,435,387...41,483,643
G
BDNF
brain derived neurotrophic factor
ISO
associated with morphine withdrawal disorder;mRNA:decreased expression:nucleus accumbens
RGD
PMID:12836135 PMID:31693870
RGD:401959588 RGD:734644
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
G
CCKBR
cholecystokinin B receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8878350
NCBI chr 1:58,555,463...58,569,949
Ensembl chr 1:58,555,321...58,568,031
G
COMT
catechol-O-methyltransferase
ISO
RGD
PMID:11840516
RGD:1300383
NCBI chr19:5,775,829...5,803,260
Ensembl chr19:5,773,225...5,785,422
G
CREB1
cAMP responsive element binding protein 1
ISO
associated with morphine withdrawal disorder;protein:increased phosphorylation:nucleus accumbens
RGD
PMID:31693870
RGD:401959588
NCBI chr10:93,316,774...93,395,187
Ensembl chr10:93,316,840...93,388,832
G
HOXB8
homeobox B8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11779477
NCBI chr16:69,025,089...69,027,937
Ensembl chr16:69,025,040...69,028,392
G
HRAS
HRas proto-oncogene, GTPase
ISO
DNA:tandem repeat polymorphism:3' end:
RGD
PMID:8832771
RGD:12738360
NCBI chr 1:343,613...345,782
Ensembl chr 1:343,506...346,637
G
HTR1D
5-hydroxytryptamine receptor 1D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10621951
NCBI chr20:109,482,357...109,485,176
Ensembl chr20:109,482,863...109,483,996
G
HTR2A
5-hydroxytryptamine receptor 2A
ISO
ClinVar Annotator: match by term: Obsessive-compulsive disorder, susceptibility to
ClinVar OMIM
PMID:9635956 PMID:12476319 PMID:15364038
NCBI chr 3:24,820,029...24,884,472
Ensembl chr 3:24,820,035...24,883,432
G
HTR7
5-hydroxytryptamine receptor 7
ISO
RGD
PMID:17267119
RGD:6482188
NCBI chr 9:84,081,713...84,191,112
Ensembl chr 9:84,083,396...84,190,876
G
SLC6A4
solute carrier family 6 member 4
ISO
ClinVar Annotator: match by term: Obsessive-compulsive disorder | ClinVar Annotator: match by term: Obsessive-compulsive disorder, susceptibility to | ClinVar Annotator: match by term: Serotonin transporter activity, increased/decreased
OMIM ClinVar
PMID:7865169 PMID:8632190 PMID:8788073 PMID:11335745 PMID:11559314 PMID:11602621 PMID:11772685 PMID:12130784 PMID:12476327 PMID:12599191 PMID:12869649 PMID:12869766 PMID:12915525 PMID:12966525 PMID:14530202 PMID:14593431 PMID:14593433 PMID:14735161 PMID:15037864 PMID:15108187 PMID:15263905 PMID:15520364 PMID:15578606 PMID:15592465 PMID:15635638 PMID:15642926 PMID:15691525 PMID:15729746 PMID:15824745 PMID:15867107 PMID:15880108 PMID:15995945 PMID:16642437 PMID:17101915 PMID:19531786 PMID:25741868 More...
NCBI chr16:23,929,196...23,969,665
Ensembl chr16:23,927,311...23,955,616
G
SLITRK5
SLIT and NTRK like family member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20418887
NCBI chr 3:66,566,718...66,574,096
Ensembl chr 3:66,569,866...66,572,742
G
ABCB1
ATP binding cassette subfamily B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12082591
NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
G
COL1A2
collagen type I alpha 2 chain
ISO
ClinVar Annotator: match by term: Orthostatic hypotension
ClinVar
NCBI chr21:54,602,780...54,639,832
Ensembl chr21:54,602,398...54,632,780
G
GNB3
G protein subunit beta 3
susceptibility
ISO
DNA:SNP: : 825C>T (human)
RGD
PMID:11910300
RGD:1580406
NCBI chr11:6,873,043...6,880,676
Ensembl chr11:6,874,351...6,880,179
G
LOC103243509
neuroendocrine secretory protein 55
susceptibility
ISO
DNA:SNP: : 393T>C(human)
RGD
PMID:11910300
RGD:1580406
NCBI chr 2:5,233,893...5,303,433
Ensembl chr 2:5,233,874...5,249,192
G
OPRD1
opioid receptor delta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2981652
NCBI chr20:103,950,505...104,002,459
G
OPRM1
opioid receptor mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2981652
NCBI chr13:81,568,295...81,650,005
Ensembl chr13:81,568,732...81,625,088
G
CYB561
cytochrome b561
ISO
ClinVar Annotator: match by term: Orthostatic hypotension 2
OMIM ClinVar
NCBI chr16:57,831,350...57,850,225
Ensembl chr16:57,839,614...57,844,989
G
SLC6A2
solute carrier family 6 member 2
ISO
ClinVar Annotator: match by term: SLC6A2-related disorder
OMIM ClinVar
PMID:25741868 PMID:28492532
NCBI chr 5:41,434,004...41,482,568
Ensembl chr 5:41,435,387...41,483,643
G
ADORA2A
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12825092
NCBI chr19:7,691,678...7,706,781
Ensembl chr19:7,691,536...7,706,926
G
ADRA2A
adrenoceptor alpha 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14656453
NCBI chr 9:104,015,577...104,019,364
Ensembl chr 9:104,016,580...104,017,932
G
CCKBR
cholecystokinin B receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8878350 PMID:15354400
RGD:1358454
NCBI chr 1:58,555,463...58,569,949
Ensembl chr 1:58,555,321...58,568,031
G
COMT
catechol-O-methyltransferase
ISO
ClinVar Annotator: match by term: CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM
ClinVar
PMID:7304673 PMID:7585135 PMID:8807664 PMID:8886163 PMID:8941353 PMID:9110364 PMID:10395222 PMID:10459407 PMID:11171904 PMID:11381111 PMID:11502905 PMID:11772685 PMID:11925305 PMID:12192614 PMID:12359690 PMID:12402217 PMID:12436243 PMID:12595695 PMID:12611827 PMID:12716966 PMID:12842306 PMID:14966473 PMID:15169701 PMID:15457404 PMID:15457497 PMID:15645182 PMID:15652872 PMID:15821730 PMID:15824744 PMID:15935994 PMID:16043133 PMID:16130008 PMID:16135635 PMID:16275815 PMID:16513880 PMID:16542388 PMID:17504906 PMID:21280081 PMID:25741868 More...
NCBI chr19:5,775,829...5,803,260
Ensembl chr19:5,773,225...5,785,422
G
CRH
corticotropin releasing hormone
ISO
RGD
PMID:14675801
RGD:1358525
NCBI chr 8:62,052,155...62,056,424
Ensembl chr 8:62,052,592...62,053,182
G
HTR1A
5-hydroxytryptamine receptor 1A
ISO
RGD
PMID:20817074 PMID:21421022
RGD:5683630 RGD:5683631
NCBI chr 4:60,159,542...60,162,947
Ensembl chr 4:60,159,944...60,161,212
G
INS
insulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12073167
NCBI chr 1:1,965,128...1,969,090
G
MANEA
mannosidase endo-alpha
susceptibility
ISO
associated with substance dependence; DNA:SNP:3'utr: (rs1133503) (Human)
RGD
PMID:24473444
RGD:401851911
NCBI chr13:20,496,677...20,529,201
Ensembl chr13:20,496,686...20,530,819
G
MAOA
monoamine oxidase A
ISO
RGD
PMID:15670397
RGD:1600723
NCBI chr X:40,834,158...40,920,404
Ensembl chr X:40,834,159...40,920,444
G
MBL2
mannose binding lectin 2
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:24856568
RGD:12910826
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
G
TPH2
tryptophan hydroxylase 2
susceptibility
ISO
DNA:SNP:intron: (rs1386494) (human)
RGD
PMID:17123728
RGD:5686356
NCBI chr11:67,568,744...67,664,911
G
CAT
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15309392
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
G
HRAS
HRas proto-oncogene, GTPase
ISO
DNA:tandem repeat polymorphism:3' end:
RGD
PMID:8832771
RGD:12738360
NCBI chr 1:343,613...345,782
Ensembl chr 1:343,506...346,637
G
MED12
mediator complex subunit 12
ISO
DNA:mutation:multiple
RGD
PMID:12216017
RGD:1358728
NCBI chr X:60,915,796...60,939,220
Ensembl chr X:60,915,703...60,937,677
G
PRL
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2554359
NCBI chr17:49,922,750...49,938,084
Ensembl chr17:49,928,321...49,938,631
G
BAX
BCL2 associated X, apoptosis regulator
ISO
RGD
PMID:23381833
RGD:10054113
NCBI chr 6:42,186,028...42,193,105
G
BCL2
BCL2 apoptosis regulator
ISO
RGD
PMID:23381833
RGD:10054113
NCBI chr18:16,440,560...16,643,187
Ensembl chr18:16,441,733...16,637,895
G
BDNF
brain derived neurotrophic factor
susceptibility treatment
ISO
DNA:missense mutation:cds:196G>A (p.V66M) (human)
RGD
PMID:23319005 PMID:28791385
RGD:10059367 RGD:401940159
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
G
CACNA1C
calcium voltage-gated channel subunit alpha1 C
ISO
ClinVar Annotator: match by term: Post-traumatic stress disorder
ClinVar
PMID:32332995
NCBI chr11:2,107,722...2,753,970
Ensembl chr11:2,508,705...2,752,991
G
CASP9
caspase 9
ISO
RGD
PMID:25331812
RGD:13782181
NCBI chr20:116,772,819...116,798,402
Ensembl chr20:116,772,155...116,798,930
G
CNR1
cannabinoid receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34262461
NCBI chr13:12,626,259...12,653,253
Ensembl chr13:12,630,270...12,631,688
G
CNR2
cannabinoid receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34262461
NCBI chr20:108,777,793...108,815,738
Ensembl chr20:108,813,579...108,814,661
G
FKBP5
FKBP prolyl isomerase 5
ISO
ClinVar Annotator: match by term: Post-traumatic stress disorder
ClinVar
PMID:18349090
NCBI chr17:36,432,595...36,551,233
Ensembl chr17:36,481,024...36,552,456
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
disease_progression
ISO
RGD
PMID:27421892
RGD:405255654
NCBI chr24:52,497,465...52,501,161
Ensembl chr24:52,497,521...52,501,514
G
GRIN2A
glutamate ionotropic receptor NMDA type subunit 2A
treatment
ISO
RGD
PMID:28791385
RGD:401940159
NCBI chr 5:9,233,028...9,707,322
Ensembl chr 5:9,286,775...9,462,828
G
HSPA5
heat shock protein family A (Hsp70) member 5
ISO
RGD
PMID:25331812
RGD:13782181
NCBI chr12:12,920,705...12,925,888
Ensembl chr12:12,920,710...12,927,431
G
IL2
interleukin 2
ISO
RGD
PMID:21714072
RGD:5147887
NCBI chr 7:69,729,635...69,736,279
Ensembl chr 7:69,730,282...69,734,969
G
MDM2
MDM2 proto-oncogene
ISO
RGD
PMID:23174211
RGD:10412309
NCBI chr11:64,434,203...64,465,490
Ensembl chr11:64,434,261...64,469,890
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
mRNA, protein:altered expression:locus coeruleus (rat)
RGD
PMID:21584742
RGD:5686336
NCBI chr23:45,904,926...46,031,804
Ensembl chr23:45,904,873...46,031,125
G
NTRK2
neurotrophic receptor tyrosine kinase 2
ISO
protein:increased expression:hippocampus
RGD
PMID:20863519
RGD:5684783
NCBI chr12:95,477,612...95,836,734
Ensembl chr12:95,479,447...95,620,364
G
OPRM1
opioid receptor mu 1
severity
ISO
DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human)
RGD
PMID:22143634
RGD:401827931
NCBI chr13:81,568,295...81,650,005
Ensembl chr13:81,568,732...81,625,088
G
PDIA3
protein disulfide isomerase family A member 3
ISO
RGD
PMID:25331812
RGD:13782181
NCBI chr26:39,273,982...39,300,170
Ensembl chr26:39,272,997...39,349,966
G
WFS1
wolframin ER transmembrane glycoprotein
treatment
ISO
RGD
PMID:17968352
RGD:8694407
NCBI chr27:42,404,028...42,437,988
Ensembl chr27:42,404,084...42,438,005
G
DRD4
dopamine receptor D4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20731709
NCBI chr 1:454,018...459,582
G
NGF
nerve growth factor
ISO
protein:decreased expression:hippocampus
RGD
PMID:24407463
RGD:401976437
NCBI chr20:18,361,795...18,413,987
Ensembl chr20:18,413,108...18,413,833
G
CNTNAP2
contactin associated protein 2
susceptibility
ISO
DNA:SNP: :rs2710102(human)
RGD
PMID:21193173
RGD:13450911
NCBI chr21:114,741,918...116,988,691
G
NPPB
natriuretic peptide B
ISO
associated with Syncope;protein:increased expression:serum:
RGD
PMID:23373852
RGD:7247623
NCBI chr20:119,930,931...119,933,391
Ensembl chr20:119,932,021...119,933,197
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all